Sequencing Therapies in Renal Cell Carcinoma

Sunday, November 4
10:30 AM - 11:15 AM
Location: Great Hall 1 & 2

Learning Objectives:

Sumanta Kumar Pal, MD

Associate Clinical Professor
City of Hope

Sumanta Kumar Pal, M.D., is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is the Co-director of Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at City of Hope. Over that span of time, he has published more than 200 peer-reviewed articles that have been featured in prominent journals - The Journal of Clinical Oncology, Lancet Oncology, Cancer Cell, and European Urology.

Dr. Pal holds patents for new drugs currently under development in prostate cancer and maintains one of the largest portfolios of clinical trials for kidney and bladder cancer research on the west coast. He developed an integrated program that focuses on collaborations with basic science researchers and urologists. Dr. Pal’s goal is to stimulate collaborative research across multiple departments in order to discover novel therapeutic approaches for incurable diseases.

Presentation(s):

Send Email for Sumanta Pal

Kathleen D. Burns, AGACNP-BC, OCN

Nurse Practitioner
City of Hope

Presentation(s):

Send Email for Kathleen Burns

Mary E. Peterson, RN, MS, APRN, AOCNP

Nurse Practitioner
CompHealth/Locum Tenens

Presentation(s):

Send Email for Mary Peterson


Assets

Sequencing Therapies in Renal Cell Carcinoma

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Sequencing Therapies in Renal Cell Carcinoma